Notice2022-17720
Agency Information Collection Activities: Proposed Collection; Comment Request
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 17, 2022
Issuing agencies
Health and Human Services DepartmentSubstance Abuse and Mental Health Services Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 158 (Wednesday, August 17, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 158 (Wednesday, August 17, 2022)]
[Notices]
[Pages 50633-50635]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-17720]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-0361.
Comments are invited on: (a) whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Program Evaluation for Prevention Contract (PEPC)--
Strategic Prevention Framework for Prescription Drugs (SPF-Rx)
Evaluation (OMB No. 0930-0377)--Revision
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) Center for Substance Abuse Prevention (CSAP) aims to complete
a cross-site evaluation of SAMHSA's SPF-Rx grant program. SPF-Rx is
designed to address nonmedical use of prescription drugs as well as
opioid overdoses by raising awareness about the dangers of sharing
medications and by working with pharmaceutical and medical communities
on the risks of overprescribing. The SPF-Rx program aims to promote
collaboration between states/tribes and pharmaceutical and
[[Page 50634]]
medical communities to understand the risks of overprescribing to youth
ages 12-17 and adults 18 years of age and older. The program also aims
to enhance capacity for, and access to, Prescription Drug Monitoring
Program (PDMP) data for prevention purposes. This request for data
collection includes a revision from previously approved Office of
Management and Budget (OMB) instruments.
The SPF-Rx program's indicators of success are reductions in opioid
overdoses, reduction in prescription drug misuse and improved use of
PDMP data. Data collected through the tools described in this statement
will be used for the national cross-site evaluation of SAMHSA's SPF-Rx
program. This package covers continued data collection through 2023.
The Program Evaluation for Prevention Control (PEPC) team will
systematically collect and maintain an Annual Reporting Tool (ART) and
Grantee and Community Level Outcomes data modules submitted by SPF-Rx
grantees through the online Data Management System (DMS).
SAMHSA is requesting approval for data collection for the SPF-Rx
cross-site evaluation with the following instruments:
Annual Reporting Tool (ART)--The ART is a survey instrument
collected yearly to monitor state, tribal entity, and community-level
performance, and to evaluate the effectiveness of the SPF-Rx program.
This tool is completed by grantees and sub-recipient community project
directors and provides process data related to funding use and
effectiveness, organizational capacity, collaboration with community
partners, data infrastructure, planned intervention targets,
intervention implementation, evaluation, contextual factors, training
and technical assistance (T/TA) needs, and sustainability.
Grantee-and Community-Level Outcomes Modules--These modules collect
data on key SPF-Rx program outcomes, including opioid prescribing
patterns and provider use of PDMP. Grantees will provide outcomes data
at the grantee level for their state, tribal area, or jurisdiction, as
well as at the community level for each of their sub-recipient
communities.
Grantee-Level Interview--This qualitative interview will be
administered at the end of the evaluation to obtain information from
the grantee project directors on their programs, staffing, populations
of focus, infrastructure, capacity, lessons learned, and collaboration.
Annualized Data Collection Burden by Year
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Annual Reporting Tool........... \a\110 1 110 4 440
\b\ 21 1 21 3 63
Grantee-Level PDMP Outcomes \b\ 21 1 21 2.5 52.5
Module.........................
Community-Level PDMP Outcomes \b\ 21 5.2 110 1.25 137.5
Module.........................
Grantee-Level Interview......... \b\ 21 1 21 1.5 31.5
-------------------------------------------------------------------------------
FY2023.......................... 131 .............. 283 .............. 724.5
----------------------------------------------------------------------------------------------------------------
\a\ Community subrecipient respondent.
\b\ Grantee respondent.
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Annual Reporting Tool........... \a\ 110 1 110 4 440
\b\ 21 1 21 3 63
Grantee-Level PDMP Outcomes \b\ 21 1 21 2.5 52.5
Module.........................
Community-Level PDMP Outcomes \b\ 21 5.2 110 1.25 137.5
Module.........................
Grantee-Level Interview......... \b\ 0 N/A N/A 1.5 N/A
-------------------------------------------------------------------------------
FY2024.......................... 131 .............. 283 .............. 693
----------------------------------------------------------------------------------------------------------------
\a\ Community subrecipient respondent.
\b\ Grantee respondent.
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Annual Reporting Tool........... \a\ 110 1 110 4 440
\b\ 21 1 21 3 63
Grantee-Level PDMP Outcomes \b\ 21 1 21 2.5 52.5
Module.........................
Community-Level PDMP Outcomes \b\ 21 5.2 110 1.25 137.5
Module.........................
Grantee-Level Interview......... \b\ 21 1 21 1.5 31.5
-------------------------------------------------------------------------------
FY2025.......................... 131 .............. 283 .............. 724.5
----------------------------------------------------------------------------------------------------------------
\a\ Community subrecipient respondent.
\b\ Grantee respondent.
[[Page 50635]]
Send comments to Carlos Graham, SAMHSA Reports Clearance Officer,
5600 Fishers Lane, Room 15E57-A, Rockville, Maryland 20857, OR email a
copy to <a href="/cdn-cgi/l/email-protection#b3d0d2c1dfdcc09dd4c1d2dbd2def3c0d2dedbc0d29ddbdbc09dd4dcc5"><span class="__cf_email__" data-cfemail="462527342a2935682134272e272b0635272b2e3527682e2e3568212930">[email protected]</span></a>. Written comments should be
received by October 17, 2022.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022-17720 Filed 8-16-22; 8:45 am]
BILLING CODE 4162-20-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 17, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.